title: Niflumic acid differentially modulates two types of skeletal ryanodine-sensitive Ca(2+)-release channels.
abstract: The effects of niflumic acid on ryanodine receptors (RyRs) of frog skeletal muscle were studied by incorporating sarcoplasmic reticulum (SR) vesicles into planar lipid bilayers. Frog muscle had two distinct types of RyRs in the SR: one showed a bell-shaped channel activation curve against cytoplasmic Ca2+ or niflumic acid, and its mean open probability (Po) was increased by perchlorate at 20-30 mM (termed "alpha-like" RyR); the other showed a sigmoidal activation curve against Ca2+ or niflumic acid, with no effect on perchlorate (termed "beta-like" RyR). The unitary conductance and reversal potential of both channel types were unaffected after exposure to niflumic acid when clamped at 0 mV. When clamped at more positive potentials, the beta-like RyR channel rectified this, increasing the unitary current. Treatment with niflumic acid did not inhibit the response of both channels to Ca2+ release channel modulators such as caffeine, ryanodine, and ruthenium red. The different effects of niflumic acid on Po and the unitary current amplitude in both types of channels may be attributable to the lack or the presence of inactivation sites and/or distinct responses to agonists.
authors.affiliation: Department of Physiology, Nagoya City University Medical School, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Oba
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D000431:Ethanol / Q000494:pharmacology; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology*; D007700:Kinetics; D008051:Lipid Bilayers; D008861:Microsomes / Q000187:drug effects / Q000502:physiology; D009544:Niflumic Acid / Q000494:pharmacology*; D010472:Perchlorates / Q000494:pharmacology; D011892:Rana catesbeiana; D012430:Ruthenium Red / Q000494:pharmacology; D019837:Ryanodine Receptor Calcium Release Channel / Q000187:drug effects / Q000502:physiology*; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000502:physiology*; D017670:Sodium Compounds / Q000494:pharmacology; D013997:Time Factors
chemical_list: D008051:Lipid Bilayers; D010472:Perchlorates; D019837:Ryanodine Receptor Calcium Release Channel; D017670:Sodium Compounds; D012430:Ruthenium Red; D000431:Ethanol; D009544:Niflumic Acid; C031068:sodium perchlorate; D002118:Calcium